Louise Lannefors
-
- Cystic Fibrosis Research Advances 16
- Neonatal Respiratory Health Research 6
- Respiratory Support and Mechanisms 6
- Tracheal and airway disorders 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Inhalation and Respiratory Drug Delivery 3
- Speech and Hearing top 5%
- Dysphagia Assessment and Management 4
- Emergency Medical Services top 10%
-
- Long-Term Effects of COVID-19 3
- Co-authors
- Per WollmerMonika Fagevik OlsénElisabeth WesterdahlR KornfältP. DiotKaren HeslopBertrand DautzenbergMauro Carone
- Partner nations
- SwedenUnited KingdomAustralia
In The Last Decade
Louise Lannefors
21 papers receiving 793 citations
Peers
Comparison fields: 5 of 101
- Pulmonary and Respiratory Medicine 717
- Speech and Hearing 77
- Physiology 141
- Critical Care and Intensive Care Medicine 24
- Emergency Medical Services 32
Countries citing papers authored by Louise Lannefors
This map shows the geographic impact of Louise Lannefors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Lannefors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Lannefors more than expected).
Fields of papers citing papers by Louise Lannefors
This network shows the impact of papers produced by Louise Lannefors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Lannefors. The network helps show where Louise Lannefors may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Louise Lannefors, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 5 | |
| 7 | 2018 | 0 | |
| 8 | 2015 | 21 | |
| 9 | 2014 | 127 | |
| 10 | 2014 | 68 | |
| 11 | 2012 | 4 | |
| 12 | 2009 | 16 | |
| 13 | 2008 | 1 | |
| 14 | 2007 | 106 | |
| 15 | Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments. | 2004 | 55 |
| 16 | 2002 | 34 | |
| 17 | 2001 | 203 | |
| 18 | 1999 | 91 | |
| 19 | 1998 | 3 | |
| 20 | 1992 | 99 |
About Louise Lannefors
Louise Lannefors is a scholar working on Speech and Hearing, Pulmonary and Respiratory Medicine and Neurology, having authored 24 papers that have together received 851 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (6 papers), Respiratory Support and Mechanisms (6 papers), Tracheal and airway disorders (5 papers), Dysphagia Assessment and Management (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (717 citations), Speech and Hearing (77 citations) and Physiology (141 citations). Louise Lannefors has collaborated with scholars based in Sweden, United Kingdom and Australia. Frequent co-authors include Per Wollmer, Monika Fagevik Olsén, Elisabeth Westerdahl, R Kornfält, P. Diot, Karen Heslop, Bertrand Dautzenberg, Mauro Carone, Torsten Bauer and Naila Svitacheva.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.